tiprankstipranks
Trending News
More News >

New Portfolio - New Portfolio

Joe Barnes

New Portfolio
Individual Investor
Ranked #414,052 out of 827,859 TipRanks' Investors
Success Rate
35%
54 out of 155
profitable transactions
Average Return
33.28%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 9.30%
6-Month Return▲ 38.40%
12-Month Return▲ 31.38%
YTD Return▲ 32.01%
Total Return▲ 13.80%

Best Trade

Opened at
Closed at-
Gain▲ 591.26%

Bio

My investment portfolio

Performance

14.73%0-14.73%
▲ 0.80%
▼ 0.87%
▼ 4.51%
Apr 2025
▲ 11.64%
▲ 6.28%
▼ 2.73%
May 2025
▲ 9.25%
▲ 5.14%
▲ 14.73%
Jun 2025
▲ 7.60%
▲ 2.30%
▲ 8.53%
Jul 2025
▲ 2.76%
▲ 2.05%
▲ 8.05%
Aug 2025
▲ 12.88%
▲ 3.56%
▼ 0.33%
Sep 2025
▲ 10.96%
▲ 2.38%
▲ 4.82%
Oct 2025
▼ 1.52%
▼ 0.09%
▲ 2.51%
Nov 2025
TipRanks AverageS&P 500Investor Portfolio
▲ 0.80%▼ 0.87%▼ 4.51%
▲ 11.64%▲ 6.28%▼ 2.73%
▲ 9.25%▲ 5.14%▲ 14.73%
▲ 7.60%▲ 2.30%▲ 8.53%
▲ 2.76%▲ 2.05%▲ 8.05%
▲ 12.88%▲ 3.56%▼ 0.33%
▲ 10.96%▲ 2.38%▲ 4.82%
▼ 1.52%▼ 0.09%▲ 2.51%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Nuvation Bio
0%
▼ 1.19%
1
Open
Oct 25, 2025
Intel
0%
▲ 29.11%
1
Open
Sep 23, 2025
Palantir Technologies
0%
▲ 4.61%
1
Open
Sep 23, 2025
Quantum Computing
0%
▼ 44.22%
1
Open
Sep 23, 2025
AT&T
0%
▼ 0.43%
1
Open
Mar 13, 2025
T Mobile US
0%
▼ 17.59%
1
Open
Mar 13, 2025
Marinus
▼ 94.54%
4
Close
Feb 10, 2025
Bellerophon
▼ 99.82%
4
Close
Dec 18, 2024
Applied Digital Corporation
0%
▲ 211.90%
1
Open
Nov 19, 2024
Pulmatrix
0%
▼ 22.91%
3
Open
Nov 17, 2024
BYD Company
0%
▲ 11.97%
1
Open
Nov 12, 2024
Devon Energy
9.2%
▼ 36.38%
16
Buy
Apr 06, 2024
Ardelyx
41.36%
▲ 62.81%
9
Buy
Jan 25, 2024
Oncolytics Biotech
0%
▼ 43.46%
1
Open
Jun 18, 2023
Immuneering
0%
▼ 40.98%
1
Open
Jun 18, 2023
Adverum Biotechnologies
0%
▼ 71.51%
1
Open
Jun 18, 2023
Carisma Therapeutics
0%
▼ 54.98%
3
Open
May 04, 2023
Nvidia
0%
▲ 281.67%
3
Open
Apr 03, 2023
Assertio Therapeutics
4.18%
▼ 81.54%
6
Sell
Mar 13, 2023
GlobalFoundries Inc
0.53%
▼ 39.72%
10
Sell
Mar 09, 2023